We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Photodynamic Therapy, Luminol Used to Kill Cancer cells

By Biotechdaily staff writers
Posted on 02 Aug 2006
Forcing cancer cells to light up could activate light-sensitive drugs that are then able to kill them without damaging nearby healthy tissue, according to recent research.

Researchers based at the College of Judea and Samaria (Ariel) and in association with Bar-Ilan University (Ramat Gan), both in Israel, have for the first time combined two novel techniques to target cancer cells. More...
The first is a form of photodynamic therapy, which delivers a light-sensitive drug specifically to cancer cells. The second technique uses a compound called luminol to generate light inside individual cells, activating the drug and killing the cell. The scientists reported their findings in the July 18, 2006, edition of the British Journal of Cancer.

Photodynamic therapy exploits the properties of specific chemicals that are triggered by normal visible light. In photodynamic therapy, laser light is shone from outside the body to activate chemotherapy drugs. Now it may be possible to use luminol to produce light inside cells, reducing side effects, and enabling the therapy to be used to treat a wider range of tumors.

Lead researcher Dr. Michael Firer, of the department of chemical engineering and Biotechnology at the College of Judea and Samaria, said, "The two big problems with photodynamic therapy are getting the light-sensitive drug to only target cancer cells, and delivering light to the drug to activate it once it is in the right place. We've uniquely combined two cutting-edge technologies to direct a drug to cancer cells and to generate a light source inside the cells. This stops the drug from killing healthy cells. It also means that we might be able to use photodynamic therapy to treat tumors deep inside the body that external light sources cannot reach. We've shown it works in the lab--if it works in real life, we'll have an exciting new way to treat cancer.”

Another unexpected and positive result of using targeted photodynamic therapy was that it removed the drug resistance that develops when untargeted therapies are employed.

Prof. John Toy, medical director of Cancer Research UK, which owns the British Journal of Cancer, remarked, "These are promising results, although there is a long way to go before we can know if this will work in patients. If it does work, it could become a safe, non-invasive option for treating many types of cancers.”



Related Links:
College of Judea and Samaria
Bar-Ilan University

New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Automated Biochemical Analyzer
iBC 900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: Brain biomarkers of Alzheimer\'s disease can be detected as early as middle age (Photo courtesy of University of Shutterstock)

Blood-Based Biomarkers Could Detect Alzheimer's as Early as Middle Age

As the global population ages, Alzheimer's disease and other dementing diseases are becoming more prevalent. The disease processes leading to Alzheimer's symptoms can begin years or even decades before... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.